These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 22797007)
1. Mutant ubiquitin decreases amyloid β plaque formation in a transgenic mouse model of Alzheimer's disease. van Tijn P; Dennissen FJ; Gentier RJ; Hobo B; Hermes D; Steinbusch HW; Van Leeuwen FW; Fischer DF Neurochem Int; 2012 Oct; 61(5):739-48. PubMed ID: 22797007 [TBL] [Abstract][Full Text] [Related]
2. Paradoxical effects of mutant ubiquitin on Aβ plaque formation in an Alzheimer mouse model. Verheijen BM; Stevens JAA; Gentier RJG; van 't Hekke CD; van den Hove DLA; Hermes DJHP; Steinbusch HWM; Ruijter JM; Grimm MOW; Haupenthal VJ; Annaert W; Hartmann T; van Leeuwen FW Neurobiol Aging; 2018 Dec; 72():62-71. PubMed ID: 30216939 [TBL] [Abstract][Full Text] [Related]
3. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease. Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747 [TBL] [Abstract][Full Text] [Related]
4. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice. Rijal Upadhaya A; Capetillo-Zarate E; Kosterin I; Abramowski D; Kumar S; Yamaguchi H; Walter J; Fändrich M; Staufenbiel M; Thal DR Neurobiol Aging; 2012 Nov; 33(11):2641-60. PubMed ID: 22305478 [TBL] [Abstract][Full Text] [Related]
5. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease. Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725 [TBL] [Abstract][Full Text] [Related]
6. Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer's disease. Izco M; Martínez P; Corrales A; Fandos N; García S; Insua D; Montañes M; Pérez-Grijalba V; Rueda N; Vidal V; Martínez-Cué C; Pesini P; Sarasa M Neuroscience; 2014 Mar; 263():269-79. PubMed ID: 24447596 [TBL] [Abstract][Full Text] [Related]
7. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities. Savonenko A; Xu GM; Melnikova T; Morton JL; Gonzales V; Wong MP; Price DL; Tang F; Markowska AL; Borchelt DR Neurobiol Dis; 2005 Apr; 18(3):602-17. PubMed ID: 15755686 [TBL] [Abstract][Full Text] [Related]
8. Enoxaparin treatment administered at both early and late stages of amyloid β deposition improves cognition of APPswe/PS1dE9 mice with differential effects on brain Aβ levels. Timmer NM; van Dijk L; van der Zee CE; Kiliaan A; de Waal RM; Verbeek MM Neurobiol Dis; 2010 Oct; 40(1):340-7. PubMed ID: 20600909 [TBL] [Abstract][Full Text] [Related]
9. Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models. Pereson S; Wils H; Kleinberger G; McGowan E; Vandewoestyne M; Van Broeck B; Joris G; Cuijt I; Deforce D; Hutton M; Van Broeckhoven C; Kumar-Singh S J Pathol; 2009 Oct; 219(2):173-81. PubMed ID: 19557827 [TBL] [Abstract][Full Text] [Related]
10. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease. Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767 [TBL] [Abstract][Full Text] [Related]
11. Stromal cell-derived factor 1α decreases β-amyloid deposition in Alzheimer's disease mouse model. Wang Q; Xu Y; Chen JC; Qin YY; Liu M; Liu Y; Xie MJ; Yu ZY; Zhu Z; Wang W Brain Res; 2012 Jun; 1459():15-26. PubMed ID: 22560596 [TBL] [Abstract][Full Text] [Related]
12. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern. Melnikova T; Savonenko A; Wang Q; Liang X; Hand T; Wu L; Kaufmann WE; Vehmas A; Andreasson KI Neuroscience; 2006 Sep; 141(3):1149-62. PubMed ID: 16753269 [TBL] [Abstract][Full Text] [Related]
13. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease. Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075 [TBL] [Abstract][Full Text] [Related]
14. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease. Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161 [TBL] [Abstract][Full Text] [Related]
15. Long-term proteasome dysfunction in the mouse brain by expression of aberrant ubiquitin. Fischer DF; van Dijk R; van Tijn P; Hobo B; Verhage MC; van der Schors RC; Li KW; van Minnen J; Hol EM; van Leeuwen FW Neurobiol Aging; 2009 Jun; 30(6):847-63. PubMed ID: 18760506 [TBL] [Abstract][Full Text] [Related]
16. RAGE regulates BACE1 and Abeta generation via NFAT1 activation in Alzheimer's disease animal model. Cho HJ; Son SM; Jin SM; Hong HS; Shin DH; Kim SJ; Huh K; Mook-Jung I FASEB J; 2009 Aug; 23(8):2639-49. PubMed ID: 19332646 [TBL] [Abstract][Full Text] [Related]
17. Divergent Age-Dependent Conformational Rearrangement within Aβ Amyloid Deposits in APP23, APPPS1, and Parvin F; Haglund S; Wegenast-Braun B; Jucker M; Saito T; Saido TC; Nilsson KPR; Nilsson P; Nyström S; Hammarström P ACS Chem Neurosci; 2024 May; 15(10):2058-2069. PubMed ID: 38652895 [TBL] [Abstract][Full Text] [Related]
18. Limited expression of heparan sulphate proteoglycans associated with Aβ deposits in the APPswe/PS1dE9 mouse model for Alzheimer's disease. Timmer NM; Herbert MK; Kleinovink JW; Kiliaan AJ; De Waal RM; Verbeek MM Neuropathol Appl Neurobiol; 2010 Oct; 36(6):478-86. PubMed ID: 20831743 [TBL] [Abstract][Full Text] [Related]
19. Human apolipoprotein E2 promotes parenchymal amyloid deposition and neuronal loss in vasculotropic mutant amyloid-β protein Tg-SwDI mice. Xu F; Vitek MP; Colton CA; Previti ML; Davis J; Van Nostrand WE J Alzheimers Dis; 2012; 31(2):359-69. PubMed ID: 22635103 [TBL] [Abstract][Full Text] [Related]
20. Efficient near-infrared in vivo imaging of amyoid-β deposits in Alzheimer's disease mouse models. Schmidt A; Pahnke J J Alzheimers Dis; 2012; 30(3):651-64. PubMed ID: 22460331 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]